Key facts
- Notable investors include SOSV, IndieBio.
- Status: Privately Held (backing).
- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Gilly Biotechnologies
- ·The full record, as it builds
Funding rounds
No funding rounds for Gilly Biotechnologies are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Gilly Biotechnologies
Developer of a biotechnology platform designed to support research and development in life sciences. The company offers experimental workflows, validation processes, and product development capabilities, enabling pharmaceutical and healthcare organizations conduct research and progress toward clinical development.
- Sector
- Healthcare
- HQ
- San Francisco, CA, United States
- Founded
- 2025
- Ownership
- Privately Held (backing)
Gilly Biotechnologies doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Gilly Biotechnologies shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Gilly Biotechnologies in its N-PORT filings yet. We sweep new filings monthly.